Rachael Griffiths

Rachael Griffiths has a strong background in pharmacovigilance and medical writing. Rachael is currently working as the Director Pharmacovigilance Scientist at Sage Therapeutics since August 2022. Prior to this, they worked at Effective Medical Ltd as a Principal Medical Writer from April 2021 to August 2022. From February 2018 to April 2021, they were the Company Director/Medical Writer at Griffiths Medical Writing Ltd. Rachael also has experience at Shire, where they held various roles including Associate Director of Pharmacovigilance, Deputy EEA Qualified Person for Pharmacovigilance, Pharmacovigilance Manager, Senior Pharmacovigilance Scientist, and Pharmacovigilance Scientist between 2006 and 2017. Earlier in their career, they worked as a Drug Safety Scientist at Eli Lilly and Company from September 2004 to December 2006. Overall, Rachael Griffiths has a diverse background in pharmacovigilance and medical writing, with extensive experience at multiple companies.

Rachael Griffiths completed their undergraduate education from 2001 to 2004, earning a BSc Hons degree in Biomedical Science from the University of Southampton. In addition to their formal education, Rachael obtained several certifications related to assertiveness, leadership, time management, decision-making, communication, and other professional skills. Rachael completed these certifications primarily through LinkedIn, with the most recent certifications obtained in 2022.